Special tissue microbiota such as Cyanobacteria are associated with the immune microenvironment of lung adenocarcinoma

蓝藻等特殊组织微生物群与肺腺癌的免疫微环境相关。

阅读:1

Abstract

BACKGROUND: Lung cancer is the leading prevalent form of human cancer and has the highest mortality rate among all cancer types. The role and potential mechanism of the lung microbiome in lung cancer is still unknown. This study aims to investigate the microbiomes of lung cancer patients possessing different levels of infiltrated CD8(+) T cells and programmed cell death-1 (PD-1) receptors, and further assess the correlation between specific microbes and the immune environment of lung tumor. METHODS: We analyzed the microbiomes of lung cancer tissues from patients with different levels of infiltrated CD8(+) T cells and PD-1 expression using 16S rRNA gene sequencing. The relative abundance of dominant phyla and genera was compared, and the correlation between microbial composition and immune markers was explored. RESULTS: Our results showed that lung cancer tissues displayed similar microbiome profiles, including Proteobacteria, Bacteroidetes, and Actinobacteria as the dominant phyla; and Chryseobacterium, Triticum aestivum (bread wheat), and Acinetobacter as the dominant genera. We found that the relative abundance of Chryseobacterium was positively correlated with CD8(+) T cell infiltration and the level of PD-1 expression, while the relative abundance of Acinetobacter was negatively associated with the PD-1 level. In addition, higher beta diversity was identified in samples with low CD8(+) T cell infiltration, but no significant correlation between beta diversity and PD-1 expression was observed. Furthermore, the relative abundance of Cyanobacteria was significantly higher in both the CD8 high and PD-1 high groups. CONCLUSIONS: Our study indicated that the lung microbiota played an indispensable role in the CD8(+) T cell-mediated tumor immune response. These findings shed light on valuable insights into the intricate interplay between the lung microbiome and the immune system in the progression of lung cancer, offing potential therapeutic strategies targeting the lung microbiome.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。